Ausejo, Ayesha Kendra E.

HRN: 26-44-16  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2026
CEFUROXIME 750MG (VIAL)
03/18/2026
03/25/2026
IV
250MG
Q8h
PCAP C
Checking Initial Appropriateness 
03/19/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/19/2026
03/26/2026
IV
50mg
Q8
PCAP
Checking Initial Appropriateness 
03/19/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/19/2026
03/26/2026
IV
750mg
Q6
PCAP
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: